Xponance, Inc. Bristol Myers Squibb CO Transaction History

Xponance, Inc.

$11.7 Billion
Q2 2025

A detailed history of Xponance, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Xponance, Inc. holds 410,983 shares of BMY stock, worth $20 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

410,983

Previous 363,979 12.91%

Holding current value

$20 Million

Previous $22.2 Million 14.3%

% of portfolio

0.16%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$44.12 - $59.6 $2.07 Million - $2.8 Million	47,004 Added 12.91%	410,983 $19 Million
Q1 2025 Apr 30, 2025	BUY	$53.9 - $63.11 $1.62 Million - $1.9 Million	30,040 Added 9.0%	363,979 $22.2 Million
Q4 2024 Feb 10, 2025	BUY	$51.92 - $59.94 $590,330 - $681,517	11,370 Added 3.52%	333,939 $18.9 Million
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $205,756 - $268,479	5,188 Added 1.63%	322,569 $16.7 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $1.03 Million - $1.35 Million	25,543 Added 8.75%	317,381 $13.2 Million
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $689,424 - $781,673	14,369 Added 5.18%	291,838 $15.8 Million
Q4 2023 Jan 31, 2024	BUY	$48.48 - $57.85 $971,054 - $1.16 Million	20,030 Added 7.78%	277,469 $14.2 Million
Q3 2023 Oct 23, 2023	BUY	$57.89 - $64.73 $187,042 - $209,142	3,231 Added 1.27%	257,439 $14.9 Million
Q2 2023 Jul 13, 2023	SELL	$63.71 - $70.74 $306,827 - $340,683	-4,816 Reduced 1.86%	254,208 $16.3 Million
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $350,168 - $397,170	5,329 Added 2.1%	259,024 $18 Million
Q4 2022 Jan 23, 2023	BUY	$68.48 - $81.09 $2.34 Million - $2.77 Million	34,161 Added 15.56%	253,695 $0
Q3 2022 Oct 24, 2022	BUY	$0.13 - $76.84 $6,239 - $3.69 Million	47,993 Added 27.98%	219,534 $15.6 Million
Q2 2022 Aug 02, 2022	BUY	$72.62 - $79.98 $1.83 Million - $2.02 Million	25,261 Added 17.27%	171,541 $13.2 Million
Q1 2022 Apr 20, 2022	BUY	$61.48 - $73.72 $116,689 - $139,920	1,898 Added 1.31%	146,280 $10.7 Million
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $1.44 Million - $1.68 Million	-26,888 Reduced 15.7%	144,382 $9 Million
Q3 2021 Nov 05, 2021	SELL	$59.17 - $69.31 $684,182 - $801,431	-11,563 Reduced 6.32%	171,270 $10.1 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $4.86 Million - $5.29 Million	-78,458 Reduced 30.03%	182,833 $12.2 Million
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $129,717 - $145,893	-2,186 Reduced 0.83%	261,291 $16.5 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $184,825 - $209,441	3,201 Added 1.23%	263,477 $16.3 Million
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $1.02 Million - $1.13 Million	-17,773 Reduced 6.39%	260,276 $15.7 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $15.2 Million - $17.8 Million	278,049 New	278,049 $16.3 Million

Others Institutions Holding BMY

# of Institutions

2,667

Shares Held

1.62B

Call Options Held

22.2M

Put Options Held

25.3M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account